Everolimus

Everolimus is a derivative of sirolimus and works as an inhibitor of mammalian target of rapamycin (mTOR). It has been approved by the FDA for use in the treatment of certain breast cancer, pancreatic cancer, renal cell cancer and other tumours. Also, it is used as an immunosuppressant to prevent rejection of organ transplants.

Additional Information

Product Name: Everolimus
Also Known As: N/A
Catalog No.: F6140
Size: 5 mg
CAS: 159351-69-6
Formula: C53H83NO14
Molecular Weight: 5958.22 g/mol
Form: Powder
Quality Assurance: >98% by HPLC and NMR
Source: Synthetic
Storage: Eligible for room temperature shipping. Store at -20°C upon receiving; protect from air and ligh
PDF Data Sheet: Download PDF datasheetMSDS
Image(s): N/A
Shipping Method: Room temperature shipping
References: Eisen HJ, et al. (2003). N. Engl. J. Med. 349 (9): 847–58.

Details

Everolimus is a derivative of sirolimus and works as an inhibitor of mammalian target of rapamycin (mTOR). It has been approved by the FDA for use in the treatment of certain breast cancer, pancreatic cancer, renal cell cancer and other tumours. Also, it is used as an immunosuppressant to prevent rejection of organ transplants.